HPV-positive types of SCCHN are driven by the integration of HPV DNA into the host genome and the activation of specific and consistent molecular regulators, including p16INK4, representing a distinct SCCHN entity [3]. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.